Search
MYHEP ALL 400 MG / 100 MG, Comprimé pelliculé
Details
| --- | Description |
|---|---|
| Pack | Boite de 28 |
| Strength (Dosage) | 400 MG / 100 MG |
| Laboratory | MYLAN PHARMACEUTICALS |
| Ingredients | Sofosbuvir | Velpatasvir |
| Therapeutic class | Antiviraux à usage systémique ; Antiviral à action directe |
| ATC code | J05AP55 |
| PPH | $411.20 |
| PPV | $439.50 |
| Refundable | Yes |
| Refund base | $439.50 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Not specified |
| Uses | Epclusa est indiqué pour le traitement de l’infection chronique par le virus de l’hépatite C (VHC) chez les adultes |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem